baber/WOPTO huggingface dataset:
Patent NZ-552352-A (NZ)
Title: Dairy product produced from milk protein isolate or milk protein concentrate with reduced calcium and phosphate ion concentrations
Inventor: COKER CHRISTINA JUNE
Filed: 2006-12-22
Abstract: Disclosed is a calcium- and phosphate-depleted milk protein concentrate (MPC) or isolate (MPI) with 10-100% depletion of both ions. This may be prepared by use of cation exchange together with one or more of anion exchange, ultrafiltration/diafiltration and electrodialysis. The products are useful in the manufacture of processed cheese, yoghurts, spreads, cheese, dairy desserts and other milk protein products.
Patent NZ-556130-A (NZ)
Title: Reciprocating slat conveyor with V-slats
Inventor: FOSTER RAYMOND KEITH
Filed: 2006-01-30
Abstract: A reciprocating slat conveyor is disclosed. The reciprocating slat conveyor comprises a plurality of laterally spaced apart movable slats, a plurality of laterally spaced apart fixed slats between the movable slats, where the movable slats have a forward position and a rearward position, and a frame below the slats. The rear end portion of the frame includes an apron that slopes downwardly and rearwardly, where the rear position of the movable slats is closer to the rear end of the apron than to the front end of the apron, and the forward position of the movable slats is closer to the front end of the apron than to the rear end of the apron. A plurality of laterally spaced apart support brackets project rearwardly from the apron, each in line with a related movable slat. The support brackets have upper portions on rear end portions of the movable slats that move when the slats move rearwardly from their forward positions to their rearward positions, and forwardly from their rearward positions to their forward positions. A space located laterally between the brackets is provided through which material on the movable slats can fall, onto the sloping apron.
Patent NZ-565370-A (NZ)
Title: Drying apparatus
Inventor: DYSON JAMES
IPC: A47K10/48
Filed: 2006-06-15
Abstract: Drying apparatus (10) has a casing (12), a cavity (30) formed in the casing for receiving an object, a fan (40) located in the casing and capable of creating an airflow, a motor (39) arranged to drive the fan. At least one opening (60, 62) communicates with the fan and is arranged in the casing so as to direct an airflow transversely across the cavity. The motor has a rotor which, in use, is capable of rotating at a speed of at least 80,000 rpm. This produces a high velocity, high pressure airflow which is capable of drying an object efficiently and quickly. The apparatus is suitable for use in a hand dryer.
Patent NZ-567010-A (NZ)
Title: One at a time dispenser container for tiny screws
Inventor: BLACK BRIAN REGINALD
IPC: B65D83/02
Filed: 2006-09-29
Abstract: A dispensing container has a first compartment 22 to hold small items such as watch screws 24, a second compartment 23 from which the screws can be dispensed, and a lid 21 for the container that can be removed to allow the screws to be loaded into the container. A wall 25, 26 separates the first and second compartments except for a weir gap 28 between the top edge 27 of the wall and the under surface of the lid which is just big enough to allow only one screw at a time to pass from the first compartment to the second compartment. The weir gap can also be opened and closed by the closure wall 29 projecting from the underside of the lid as the lid is turned back and forth on the container. A screw that has been shaken into the second compartment can be dispensed from the container via the outlet aperture 31. (62) Divided Out of 550235
Patent NZ-567456-A (NZ)
Title: Anti-cancer combination of DMXAA and cyclophosphamide
Inventor: WILSON WILLIAM ROBERT
IPC: A61K33/243
Filed: 2002-09-03
Abstract: Disclosed is a synergistic combination of DMXAA (5,6-dimethylxanthenone-4-acetic acid) or a pharmaceutically acceptable salt or ester thereof and cyclophosphamide, for concomitant or sequential use in the treatment of cancer and wherein the combination is formulated to provide DMXAA in the range of from 900 to 4900 mg/m2. Also disclosed is a kit comprising DMXAA or a pharmaceutically acceptable salt or ester thereof and cyclophosphamide, which when combined produce a synergistic combination for concomitant or sequential use in the treatment of cancer and wherein the combination is formulated to provide DMXAA in the range of from 900 to 4900 mg/m2. Use of: a) DMXAA or a pharmaceutically acceptable salt or ester thereof, and b) cyclophosphamide for the manufacture of a medicament for the treatment of cancer in a patient in need thereof, wherein the medicament is formulated for simultaneous, separate or sequential administration of a) and b) and the medicament is formulated to provide DMXAA in the range of from 900 to 4900 mg/m2 is further disclosed.
Patent NZ-570788-A (NZ)
Title: Apparatus and method for loading and unloading a container from a trailer using a rolling rack
Inventor: PHILLIPS JONELLE MARIE
IPC: B65G13/00
Filed: 2007-10-12
Abstract: Disclosed is a trailer and rolling rack arrangement that allows a container to be rolled off the rolling rack to be received into a housing on the trailer. The trailer is delivered to a user's premises with the container on it. The trailer and container is left outside the user's premises, where the housing protects the container from the elements, and the user can pack the container with items to be stored. Once the container is packed with the user's goods, the trailer is towed to a storage depot where the container is rolled off the trailer onto the rolling rack. The container may then be stacked by conventional means.
Patent NZ-572231-A (NZ)
Title: Inhibitors of the task-1 and task-3 ion channel
Inventor: BRENDEL JOACHIM
IPC: A61K31/00
Filed: 2007-04-13
Abstract: Disclosed is the use of the biphenyl compounds of formula Ib wherein the substituents are disclosed within the specification for producing a medicament for the therapy of conditions selected from sleep-related respiratory disorders, central and obstructive sleep apneas, upper airway resistance syndrome and snoring.
Patent NZ-574395-A (NZ)
Title: Method and apparatus for producing a cylindrical steel pressure container with a dispensing unit at the open end
Inventor: ROETERDINK JOHAN WILLEM
IPC: B21D51/24
Filed: 2007-07-16
Abstract: Disclosed is a method for forming a steel container (1) having a curled open end, comprising the steps of : i) providing a steel cup (11); ii) deep drawing the steel cup into a drawn container preform (12) ; iii) thin drawing the body of the drawn container preform; and iv) curling an open end of the drawn container preform by forming a precurl (16) and by curling the precurl into an elongated curl (19), to an apparatus for forming a steel container, and to such steel container and its preform.
Patent NZ-587896-A (NZ)
Title: Enantiomers of beloxepin, and the use of beloxepin and its enantiomers to treat pain and other disorders
Inventor: LE BOURDONNEC BERTRAND
IPC: C07H17/08
Filed: 2009-02-19
Abstract: Disclosed is the use of an amount of beloxepin and/or an analog according to Formula I, wherein n is 0 or 1; X is 0 or S; R1 represents H or OH, halogen, alkyl and alkoxy; R2 represents H, OH, halogen, alkyl and alkoxy; R3 and R4 are two substituents which are in the cis configuration and R3 is OH and R4 is H; and R5 is H or alkyl, or a salt thereof, for the manufacture of a medicament for treating pain in a mammal.
Patent NZ-589940-A (NZ)
Title: Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
Inventor: COHEN DANIEL
IPC: A61K31/197
Filed: 2009-06-17
Abstract: Disclosed is a composition comprising pilocarpine and methimazole, or pilocarpine and carbimazole or salts thereof. Also disclosed is a combination product comprising a muscarinic receptor agonist selected from the group consisting of pilocarpine, cevimeline, carbachol, methacholine, and bethanechol and an inhibitor of thyroid hormone synthesis selected from the group consisting of methimazole, carbimazole,propylthiouracil and amiodarone, or a salt thereof, for a grouped or separate administration to a subject, simultaneously or sequentially. The use of the compositions for treating Charcot-Marie Tooth disease is also disclosed.
Patent NZ-590517-A (NZ)
Title: Nonimmunosuppressive cyclosporine analogue molecules
Inventor: ABEL MARK D
IPC: C07K7/64
Filed: 2009-07-03
Abstract: NONIMMUNOSUPPRESSIVE CYCLOSPORINE ANALOGUE MOLECULES Provided are cyclosporine analogues comprising backbone of depicted Formula I, wherein R' is H or acetyl; R1 is a straight chain or branched alkane or alkene group from 2 to 15 carbon atoms in length; and R2 is as defined. The compounds are useful in treating cyclophilin mediated diseases, including various infections, inflammations, cancers and cellular, tissue or organ degeneration.
Patent NZ-591392-A (NZ)
Title: Two uses fluid test chip
Inventor: HSIEH CHIH-WEI
IPC: G01N33/543
Filed: 2008-09-16
Abstract: Disclosed is a combinatory testing strip for performing a biochemical assay and a immunoassay simultaneously and detecting by a sensor, comprising a substrate having an upper surface concavely provided with a first channel for a biochemical assay and a second channel for an immunological assay, and each of the first and second channels having a first area for receiving a fluid sample, a second area and a third area that are connected successively, wherein the combinatory testing strip is characterized in that: at the bottom thereof, each of the second and the third area comprises a nitrocellulose layer having a hollow-matrix conformation, and the second area is for delivering the fluid sample and the third area is where the fluid sample reacts; the nitrocellulose layer of the second area comprises an average thickness which is not greater than that of the nitrocellulose layer of the third area; a reaction material is formed in the hollow-matrix conformation of the nitrocellulose layers; and both the third areas of the first and second channels are located on a line conforming a relative motion path of the sensor and the combinatory testing strip.
Patent NZ-592504-A (NZ)
Title: Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
Inventor: ZHANG BEILI
IPC: A61K31/4704
Filed: 2009-10-23
Abstract: 592504 The present disclosure relates to solid state forms, for example, crystalline forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide - compound 1, pharmaceutical compositions thereof, and methods therewith. The Form A is characterized by one or more peaks in an X-ray powder diffraction pattern selected from about 7.9, about 9.3, about 11.9, about 14.4, about 15.1, about 15.8, about 17.0, about 17.7, about 19.3, about 20.1, about 21.4, about 21.8, about 23.4, about 23.8, about 25.6, about 26.8, about 29.4, about 29.7, about 30.1 or about 31.2 degrees 2 theta.
Patent NZ-592901-A (NZ)
Title: Improvements in window fittings
Inventor: WAITAI RANA
IPC: E05C17/22
Filed: 2011-05-17
Abstract: 592901 A window limiting device (1) for a window, the window including a movable sash (25) hingedly linked to a frame. The window limiting device includes: a sash mounting, and an elongate arm (6), the arm having a first end and a second end, and a frame mounting (4), the frame mounting being linked to the sash mounting via the arm. The frame mounting is provided with an aperture through which the arm may pass. The arm is pivotally linked to the sash mounting such that the arm may move in a first plane and at least one other plane. The first end of the arm is pivotally linked to the second end of the arm, the first end of the arm being formed as a ball (9) which is configured to engage with a socket (8) of the sash mounting in a ball joint (24).
Patent NZ-597409-A (NZ)
Title: A communication system with a plurality of radio bearers with predetermined Quality of Service (QoS) set for different mobile stations and a relay node with a priority control processing unit
Inventor: TAKAHASHI HIDEAKI
IPC: H04W16/26
Filed: 2010-06-08
Abstract: Disclosed is a mobile communication system. The system includes a plurality of mobile stations, a relay node, a radio base station and a plurality of first radio bearers set between the plurality of mobile stations and the relay node. Each of the first radio bearers for a predetermined QoS is set for different mobile stations and is configured to be mapped to a second radio bearer for the predetermined QoS set between the relay node and the radio base station. The relay node includes a priority control processing unit configured to perform a priority control process for a multiplexing process to the second radio bearer for the predetermined QoS of uplink user data. The uplink user data being received via each of the first radio bearers for the predetermined QoS, based on a priority assigned to each of the first radio bearers for the predetermined QoS.
Patent NZ-599674-A (NZ)
Title: Mono-hydrochloric salts of an inhibitor of histone deacetylase
Inventor: DICKENS JULIUS W
IPC: A61K31/506
Filed: 2008-05-13
Abstract: Disclosed is a para-nitro imine piperidine of formula (I).
Patent NZ-599817-A (NZ)
Title: A bridge construction and method for modifying strain characteristics of a bridge
Inventor: TILLEY MARK ROBERT
IPC: E01D1/00
Filed: 2010-09-28
Abstract: A method of modifying strain characteristics of a bridge construction having a support structure for a deck plate. The method includes actively evacuating air from within the internal cavity to create a negative pressure differential in the internal cavity relative to its environment. Also described is a bridge construction with one or more pumps to provide a negative pressure differential within support structures for a deck plate of the bridge construction.
Patent NZ-600175-A (NZ)
Title: Water curable resin formulations
Inventor: TIAN WENDY WENJUN
IPC: C08G59/50
Filed: 2010-11-25
Abstract: Patent No. 600175 Disclosed is a water curable resin formulation comprising: a. an epoxy resin; b. an aromatic amine curing agent, wherein the molar ratio of amine functional groups in said curing agent relative the epoxy functional groups of said epoxy resin is in the range of 7:10 to 9:10, and wherein said aromatic amine curing agent is a monocyclic aromatic amine; and c. a coupling agent comprising a siloxane group coupled to an epoxy reactive group.
Patent NZ-600453-A (NZ)
Title: Inhibitors of akt activity
Inventor: ZHANG LIXIN
IPC: A61K31/4741
Filed: 2010-12-23
Abstract: ABSTRACT - 600453 The disclosure relates to a series of compounds represented by formula (I) which have a particular activity as inhibitors of the serine-threonine kinase AKT, wherein the variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising said compound of formula (I), wherein the pharmaceutical compositions are suitable for treating cancer.
Patent NZ-601033-A (NZ)
Title: Tricyclic compounds for use as kinase inhibitors
Inventor: PASTOR FERNANDEZ JOAQUIN
IPC: C07D487/14
Filed: 2010-12-31
Abstract: 601033 Disclosed herein is a compound of formula (I), wherein the variables are defined in the specifications, the use of said compounds in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PIM family kinase, such as PIM-1, PlM-2 and/or PIM-3) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease, and combinations comprising said compounds. Specific embodiments of the compound include: N-[9-methyl-3-(3-trifluoromethoxy-phenyl)-8,9-dihydro-7H-6-oxa-1,2,3a,4,9-pentaaza-cyclopenta[a]naphthalen-5-yl]-N-(2-piperazin-1-yl-ethyl)-acetamide; [2-(4-methanesulfonyl-piperazin-1-yI)-ethyl)-[9-methyl-3-(3-trifluoromethoxy-phenyl)-8,9-dihydro-7H-6-oxa-1,2,3a,4,9-pentaaza-cyclopenta[a]naphthalen-5-yl)-amine; and (1-methyl-1-oxy-piperidin4-ylmethyl)-[6-methyl-3-(3-trifluoromethoxyphenyl)-7,8-dihydro-6H-9-oxa-1,2,3a,4,6-pentaaza-cyclopenta[a]naphthalen-5-yl]-amine.
Patent NZ-620770-A (NZ)
Title: Method and system for controlling hydroelectric turbines
Inventor: SPOONER EDWARD
IPC: H02P9/48
Filed: 2012-08-10
Abstract: A control system for controlling an operation of a hydroelectric turbine (10) is disclosed. The control system comprises a converter system (20) to convert AC power, supplied by a generator (18) connected to the turbine (16), and having a voltage and frequency that is a function of a rotational speed of the turbine (16), to AC power having a voltage and frequency of a transmission system for transmitting the AC power to a receiving station. The system further comprises a control unit (32) that is arranged to co-operate with the converter system to adjust the AC voltage supplied by the generator in response to a water flow speed through the turbine to thereby control rotation of the turbine (16). The converter system comprises a first-stage converter (26) and a second-stage converter (28), with a DC link provided between the first and second-stage converters. The first-stage converter (26) is arranged to convert the AC power supplied by the generator to DC power. The second-stage converter (28) is arranged to convert the DC power to the AC Power for transmission to the receiving station and the second-stage converter (28) is of a current-source inverter type.
Patent NZ-701007-A (NZ)
Title: System and method for diagnosis of bovine diseases using auscultation analysis
Inventor: GEISSLER RANDOLPH K
IPC: G06F19/00
Filed: 2013-01-25
Abstract: A system and method are provided for diagnosis of animal respiratory diseases using auscultation techniques. Animal lung sounds are recorded and digitized. Lung sounds are obtained by an electronic digital stethoscope or a wireless audio digital recording unit. The sounds are stored as digital data, and one or more algorithms are applied to the data for producing an output to the user indicative of the health of the animal. The acoustic characteristics of the sound are compared with baseline data in the algorithms. One embodiment includes a digital stethoscope with an integral display. Another embodiment provides a system for gathering information about an animal to include not only auscultation data, but also information from other field devices such as temperature probes or weigh scales. The combined information can be analyzed by system software to generate detailed information to a user to include a diagnosis and recommended treatment options.
Patent NZ-702489-A (NZ)
Title: Wound dressing
Inventor: BONNEFIN WAYNE LEE
IPC: A61L15/60
Filed: 2013-05-30
Abstract: The present disclosure relates to the field of wound dressings. Described herein are wound dressings which sustain the release of silver ions to the wound and minimize adherence to the wound by reducing the tendency for the dressings to dehydrate during their wear time. Accordingly, described herein is a wound dressing comprising a mat of gel forming fibres comprising between about 0.1% and 20% by weight of silver, the mat having an open structure reinforced with textile fibres or threads, or fibres or threads of limited absorbency for use in the treatment of wounds, wherein the mat has a punch density of less than 60 per cm2.
Patent NZ-720141-A (NZ)
Title: Anti-phf-tau antibodies and their uses
Inventor: WU SHENG-JIUN
IPC: C07K16/00
Filed: 2012-12-19
Abstract: Disclosed are isolated antibodies that bind paired helical filament tau (PHF-tau), polynucleotides that encode such antibodies and methods of making such antibodies.
Patent NZ-725735-A (NZ)
Title: Binding molecules specific for il-21 and uses thereof
Inventor: ETTINGER CATHERINE
IPC: A61K8/64
Filed: 2015-04-07
Abstract: This disclosure provides IL-21 binding molecules, e.g., anti-IL-21 antibodies and antigen-binding fragments thereof. In certain aspects the anti-IL-21 antibodies and fragments thereof can be hybridoma-derived murine monoclonal antibodies, and humanized versions thereof. In certain aspects the binding molecules, e.g., anti-IL-21 antibodies and antigen-binding fragments thereof provided herein inhibit, suppress, or antagonize IL-21 activity. In addition, this disclosure provides compositions and methods for diagnosing and treating diseases or disorders, e.g., inflammatory, immune-mediated, or autoimmune diseases or disorders associated with IL-21 -mediated signal transduction. In a particular embodiment, the disclosure provides methods for treating or preventing Graft-versus-host disease (GVHD) using IL-21 binding molecules, e.g., anti-IL-21 antibodies and antigen-binding fragments thereof.
Patent NZ-734059-A (NZ)
Title: Ferrite core, current mutual inductor and current leakage protection switch
Inventor: FENG MA
IPC: H02H3/00
Filed: 2017-07-25
Abstract: The embodiments of the present disclosure provide a ferrite core, a current mutual inductor and a current leakage protection switch. The ferrite core includes a first portion formed by a first ferrite material which has first permeability that changes with the temperature. The ferrite core also includes a second portion formed by a second ferrite material different from the first ferrite material, the second ferrite material having second permeability that changes with temperature. The ferrite core has overall permeability that changes with the temperature. The overall permeability is determined based on the first permeability, the second permeability, a first proportion of the first portion in the ferrite core, and a second proportion of the second portion in the ferrite core. The first proportion and the second proportion are determined so that the overall permeability is higher than a threshold in a predetermined temperature range.
Patent NZ-739843-A (NZ)
Title: A seat
Inventor: SCARLETT ROYDON MARK
IPC: A61G5/12
Filed: 2018-02-12
Abstract: Some people to have postural problems due to peculiarities with their anatomy, for example spinal problems related to lordosis, kyphosis or scoliosis. Depending on the severity of the problem it may be necessary to have a seat customised to the shape of the person’s back so that they are comfortably supported when sitting. It is an object of preferred embodiments of the invention to go at least some way towards addressing this problem. It may be done so by way of a wheelchair backrest 2 comprising an upright base 4, a plurality of cushions 6, each cushion comprising a flexible envelope and fill comprising a plurality of pads. The backrest is such that the envelope of each cushion has a front face 8 formed or substantially covered with a connective hook receptive fabric, and a rear major face comprising a complimentary hooked patches. The backrest is built outwards by layering some of the cushions 6 so that the depth of the backrest varies commensurate with the shape of the user’s back. The layered cushions are at least partially held in place by engagement between the hook receptive fabric and the hooked patches.
Patent NZ-755605-A (NZ)
Title: Compositions for modulating tau expression
Inventor: FREIER SUSAN
IPC: A61K48/00
Filed: 2014-07-21
Abstract: Disclosed herein are antisense compounds and methods for decreasing Tau mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate Tau-associated diseases, disorders, and conditions.